Loading...
Tumor-infiltrating lymphocytes in the immunotherapy era
The clinical success of cancer immune checkpoint blockade (ICB) has refocused attention on tumor-infiltrating lymphocytes (TILs) across cancer types. The outcome of immune checkpoint inhibitor therapy in cancer patients has been linked to the quality and magnitude of T cell, NK cell, and more recent...
Na minha lista:
| Udgivet i: | Cell Mol Immunol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group UK
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8115290/ https://ncbi.nlm.nih.gov/pubmed/33139907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41423-020-00565-9 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|